Imaging of medullary thyroid carcinoma
- 1 November 2019
- journal article
- research article
- Published by Springer Nature in Der Radiologe
- Vol. 59 (11) , 992-1001
Abstract
Background. About 10% of thyroid cancers are medullary thyroid carcinoma (MTC) and can occur sporadically, familially and in the context of type II multiple endocrine neoplasia (MEN). Imaging plays a pivotal role in screening family members and in diagnosis. Diagnostic methods. Diagnosis is based on ultrasound (US), thyroid scintigraphy, serum calcitonin and carcinoembryonic antigen (CEA) as well as fine needle biopsy. High-resolution US is the most important imaging method for locoregional staging, combined with computed tomography (CT) of the mediastinum. Positron emission tomography (PET-CT) using 18-F-DOPA is particularly suited for suspected occult metastases in case of rising tumor markers in serum. Findings and course of disease. Diagnosis is made based on cytologic findings in a hypoechoic, cold thyroid nodule, combined with an elevation of serum calcitonin and CEA. US is the most important imaging modality during routine follow-up. CT is indicated for suspected mediastinal, lung, or liver metastases. CT should be replaced by MRI as early as possible to prevent significant cumulative radiation doses over time. Recent clinical developments. Although MTC is curable by surgery only, owing to its radio- and chemoresistance, the disease will often progress only slowly, and even patients with metastases will frequently survive 10 years or longer. For more aggressive variants and late symptomatic stages, targeted drugs that have the potential to indicate stabilization or even a partial remission of the disease are under clinical investigation or already approved.Keywords
This publication has 39 references indexed in Scilit:
- CT- and ultrasound-characteristics of hepatic lesions in patients with multiple endocrine neoplasia syndrome. A retrospective image review of 25 casesPLOS ONE, 2019
- Comparative Diagnostic Performance of Ultrasonography and 99mTc-Sestamibi Scintigraphy for Parathyroid Adenoma in Primary Hyperparathyroidism; Systematic Review and Meta- Analysis2017
- Recent Updates on the Management of Medullary Thyroid CarcinomaEndocrinology and Metabolism, 2016
- Pancreatitis with vascular endothelial growth factor receptor tyrosine kinase inhibitorsCritical Reviews in Oncology/Hematology, 2015
- Hepatotoxicity with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A meta-analysis of randomized clinical trialsCritical Reviews in Oncology/Hematology, 2015
- Detection Rate of Recurrent Medullary Thyroid Carcinoma Using Fluorine-18 Dihydroxyphenylalanine Positron Emission TomographyAcademic Radiology, 2012
- Medullary Thyroid Carcinoma: Comparison With Papillary Thyroid Carcinoma and Application of Current Sonographic CriteriaAmerican Journal of Roentgenology, 2010
- Association of Skeletal Muscle Wasting With Treatment With Sorafenib in Patients With Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled StudyJournal of Clinical Oncology, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Comparison Between Echo-Color Doppler Sonography Features and Angioarchitecture of Thyroid NodulesInternational Journal of Surgical Pathology, 2007